RenovaCare (RenovaCare) GF Value : $0.00 (As of May. 08, 2024)

View and export this data going back to . Start your Free Trial

What is RenovaCare GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-08), RenovaCare's share price is $0.0001. RenovaCare's GF Value is $0.00. Therefore, RenovaCare's Price-to-GF-Value for today is .

Based on the relationship between the current stock price and the GF Value, GuruFocus believes RenovaCare is Not Valued.

RenovaCare (OTCPK:RCAR) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

RenovaCare's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	0.0001	/	0.00
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RenovaCare GF Value Related Terms

Thank you for viewing the detailed overview of RenovaCare's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

RenovaCare (RenovaCare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RenovaCare Inc (OTCPK:RCAR) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

9375 East Shea Boulvard, Suite 107-A, Scottsdale, AZ, USA, 85260

Website

https://www.renovacareinc.com

RenovaCare Inc is a biotechnology company focusing on the acquisition, research, development and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. The company's initial products under development target skin. It offers treatment methodology for cell isolation for the regeneration of human skin cells, along with a medical-grade liquid spraying device and associated equipment (the SkinGun). RenovaCare is evaluating the efficacy and potential of SkinGun, in combination with a cell isolation method, in the treatment of tissue that has been subject to severe trauma. Geographically all the activities are functioned through the region of United States.

Executives

Patsy Trisler	officer: Vice President	430 PARK AVENUE, SUITE 702, NEW YORK NY 10022
Thomas Bold	officer: President & CEO	430 PARK AVENUE, SUITE 702, NEW YORK NY 10022
Joseph Sierchio	director	430 PARK AVENUE, SUITE 702, NEW YORK NY 10022
Kenneth Kirkland	director	430 PARK AVENUE, SUITE 702, NEW YORK NY 10022
Rhonda Beth Rosen	director, officer: President & CEO	43 DICKINSON ROAD, BASKING RIDGE NJ 07920
1420525 Alberta Ltd.	10 percent owner	1628 WEST 1ST AVENUE, SUITE 216, VANCOUVER A1 V6J1G1
David E Jenkins	director	406 NORTH HERMOSA DRIVE, PALM SPRINGS CA 92262
Antonino G Cacace	director, officer: President	CRUD-Y-GWYNT, CASWELL BAY, SWANSEA X0 SA3 3BU
Jeet Sidhu	director	5667 SUNRISE CRESCENT WEST, SURREY, BC A1 V3S 7M4
Derek Cooper	officer: President/ CEO
Frank J Fabio	officer: CFO/Sec.(Resigned 1/9/2009)	670 BROADWAY, MASSAPEQUA NY 11758
Christian F Hudson	director	33 CHURCHILL ROAD, TENAFLY NJ 07670
Harmel S Rayat	director, 10 percent owner	700 - 688 WEST HASTINGS STREET, VANCOUVER A1 V6B 1P1
Stanley Wong	officer: President/CEO
Terri Dumoulin	director, officer: Secretary/Treasurer